Detalhe da pesquisa
1.
Predictors of day-level sexual risk for young gay and bisexual men.
AIDS Behav
; 17(4): 1465-77, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22614745
2.
Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men.
AIDS Behav
; 17(4): 1478-87, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23553345
3.
More than ancillary: HIV social services, intermediate outcomes and quality of life.
AIDS Care
; 21(10): 1289-97, 2009 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-20024705
4.
A randomized controlled trial utilizing motivational interviewing to reduce HIV risk and drug use in young gay and bisexual men.
J Consult Clin Psychol
; 82(1): 9-18, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24364800
5.
The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment.
J Acquir Immune Defic Syndr
; 56 Suppl 1: S7-13, 2011 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21317598
6.
Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care.
J Acquir Immune Defic Syndr
; 56 Suppl 1: S14-21, 2011 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21317589
7.
Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients.
J Acquir Immune Defic Syndr
; 56 Suppl 1: S62-7, 2011 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21317596
8.
The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone.
J Acquir Immune Defic Syndr
; 56 Suppl 1: S54-61, 2011 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21317595
9.
Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings.
J Acquir Immune Defic Syndr
; 56 Suppl 1: S91-7, 2011 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21317601
10.
Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone.
J Acquir Immune Defic Syndr
; 56 Suppl 1: S33-8, 2011 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21317592
11.
Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics.
J Acquir Immune Defic Syndr
; 56 Suppl 1: S39-45, 2011 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21317593
12.
Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine.
J Acquir Immune Defic Syndr
; 56 Suppl 1: S83-90, 2011 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21317600
13.
The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation.
J Acquir Immune Defic Syndr
; 56 Suppl 1: S76-82, 2011 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21317599
14.
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.
J Acquir Immune Defic Syndr
; 56 Suppl 1: S22-32, 2011 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21317590
15.
Factors affecting willingness to provide buprenorphine treatment.
J Subst Abuse Treat
; 36(3): 244-51, 2009 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-18715741
16.
The CASE adherence index: A novel method for measuring adherence to antiretroviral therapy.
AIDS Care
; 18(7): 853-61, 2006 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-16971298